Back to video list Back to Home Is there a value of initiating a long-acting injectable if adherence might not be a concern? You may also like Depression Article Spreading alcohol abuse and relationship to depression during COVID-19 spread Depression Schizophrenia Article The evolving science of psychiatry Migraine Article Headache nurses role in addressing the global burden of headache Bipolar Schizophrenia Article Dopamine synthesis is the common factor in genetic and environmental risks in schizophrenia